# Edesa Biotech, Inc.: filings

EDSA · Nasdaq · CIK 1540159 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/edsa.md) · [Financials](/companies/edsa/financials.md) · [Filings](/companies/edsa/filings.md) · [Insiders](/companies/edsa/insiders.md)

## Reports and events: 333 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 217, 8-K 142, 6-K 88, 10-Q 36, 3 27, 424B5 16, UPLOAD 15, EFFECT 14, 4/A 13, SC 13D/A 13, CORRESP 12, DEF 14A 12, 10-K 11, SC 13G/A 10, SC 13G 9, D 8, S-3 8, SC 13D 8, SCHEDULE 13G 8, DEFA14A 7, S-8 7, 424B3 6, SCHEDULE 13D/A 6, SCHEDULE 13G/A 6, 8-K/A 5, ARS 5, 10-K/A 4, S-1 4, 20FR12G/A 3, 424B4 3, CT ORDER 3, 20-F 2, 3/A 2, FWP 2, POS AM 2, PRE 14A 2, 10-KT 1, 20FR12G 1, 6-K/A 1, 8-A12B 1, CERTNAS 1, D/A 1, DEF 14C 1, DEFM14A 1, NT 20-F 1, PREM14A 1, S-1/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 17:24 ET | [8-K](/filings/0001171843-26-006794.md) | 5.02 Departure or appointment of officers or directors | 0001171843-26-006794 |
| 2026-10-15 | 09:15 ET | [8-K](/filings/0001171843-26-006647.md) | 8.01 Other events | 0001171843-26-006647 |
| 2026-08-25 | 18:00 ET | [SCHEDULE 13D/A](/filings/0001171843-26-005738.md) | Ownership report, active investor, amended | 0001171843-26-005738 |
| 2026-08-25 | 16:38 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002310.md) | Ownership report, active investor, amended | 0000921895-26-002310 |
| 2026-08-20 | 16:15 ET | [8-K](/filings/0001171843-26-005686.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-005686 |
| 2026-08-13 | 16:40 ET | [10-Q](/filings/0001171843-26-005502.md) | Quarterly report, period 2026-06-30 | 0001171843-26-005502 |
| 2026-08-13 | 16:20 ET | [8-K](/filings/0001171843-26-005499.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005499 |
| 2026-06-16 | 17:06 ET | [SCHEDULE 13D/A](/filings/0001171843-26-004153.md) | Ownership report, active investor, amended | 0001171843-26-004153 |
| 2026-06-11 | 09:20 ET | [8-K](/filings/0001171843-26-004053.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004053 |
| 2026-06-05 | 09:25 ET | [8-K](/filings/0001171843-26-003931.md) | 8.01 Other events | 0001171843-26-003931 |
| 2026-05-29 | 16:15 ET | [8-K](/filings/0001171843-26-003793.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-003793 |
| 2026-05-15 | 09:08 ET | [8-K](/filings/0001171843-26-003459.md) | 5.02 Departure or appointment of officers or directors | 0001171843-26-003459 |
| 2026-05-14 | 16:50 ET | [10-Q](/filings/0001171843-26-003433.md) | Quarterly report, period 2026-03-31 | 0001171843-26-003433 |
| 2026-05-14 | 16:40 ET | [8-K](/filings/0001171843-26-003429.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003429 |
| 2026-04-03 | 16:31 ET | [DEF 14A](/filings/0001171843-26-002236.md) | Proxy statement, period 2026-05-27 | 0001171843-26-002236 |
| 2026-03-02 | 19:03 ET | [SCHEDULE 13D/A](/filings/0000921895-26-000578.md) | Ownership report, active investor, amended | 0000921895-26-000578 |
| 2026-03-02 | 17:11 ET | [SCHEDULE 13D/A](/filings/0001171843-26-001269.md) | Ownership report, active investor, amended | 0001171843-26-001269 |
| 2026-02-24 | 09:21 ET | [8-K](/filings/0001171843-26-001046.md) | 8.01 Other events | 0001171843-26-001046 |
| 2026-02-13 | 16:45 ET | [10-Q](/filings/0001171843-26-000812.md) | Quarterly report, period 2025-12-31 | 0001171843-26-000812 |
| 2026-02-13 | 16:30 ET | [8-K](/filings/0001171843-26-000810.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000810 |
| 2025-12-12 | 16:45 ET | [8-K](/filings/0001171843-25-007918.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-007918 |
| 2025-12-12 | 16:30 ET | [10-K](/filings/0001171843-25-007914.md) | Annual report, period 2025-09-30 | 0001171843-25-007914 |
| 2025-12-12 | 16:25 ET | [8-K](/filings/0001171843-25-007913.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007913 |
| 2025-10-28 | 07:45 ET | [8-K](/filings/0001171843-25-006690.md) | 8.01 Other events | 0001171843-25-006690 |
| 2025-09-30 | 16:14 ET | [8-K](/filings/0001171843-25-006188.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001171843-25-006188 |
| 2025-09-09 | 16:35 ET | [8-K](/filings/0001171843-25-005800.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-005800 |
| 2025-08-08 | 16:45 ET | [10-Q](/filings/0001171843-25-005236.md) | Quarterly report, period 2025-06-30 | 0001171843-25-005236 |
| 2025-08-08 | 16:40 ET | [8-K](/filings/0001171843-25-005235.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005235 |
| 2025-05-28 | 16:05 ET | [8-K](/filings/0001171843-25-003495.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-25-003495 |
| 2025-05-14 | 16:46 ET | [10-Q](/filings/0001171843-25-003189.md) | Quarterly report, period 2025-03-31 | 0001171843-25-003189 |
| 2025-05-14 | 16:25 ET | [8-K](/filings/0001171843-25-003183.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-003183 |
| 2025-04-04 | 16:22 ET | [DEF 14A](/filings/0001171843-25-002028.md) | Proxy statement, period 2025-05-28 | 0001171843-25-002028 |
| 2025-04-04 | 16:20 ET | [8-K](/filings/0001171843-25-002027.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-002027 |
| 2025-02-18 | 17:48 ET | [SCHEDULE 13D](/filings/0000921895-25-000528.md) | Ownership report, active investor | 0000921895-25-000528 |
| 2025-02-14 | 17:16 ET | [SCHEDULE 13D/A](/filings/0001171843-25-000871.md) | Ownership report, active investor, amended | 0001171843-25-000871 |
| 2025-02-14 | 16:46 ET | [10-Q](/filings/0001171843-25-000866.md) | Quarterly report, period 2024-12-31 | 0001171843-25-000866 |
| 2025-02-14 | 16:25 ET | [8-K](/filings/0001171843-25-000864.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-000864 |
| 2025-02-13 | 07:16 ET | [8-K](/filings/0001171843-25-000796.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-000796 |
| 2024-12-20 | 16:40 ET | [10-K/A](/filings/0001171843-24-007041.md) | Annual report, amended, period 2024-09-30 | 0001171843-24-007041 |
| 2024-12-13 | 16:45 ET | [10-K](/filings/0001171843-24-006946.md) | Annual report, period 2024-09-30 | 0001171843-24-006946 |
| 2024-12-13 | 16:40 ET | [8-K](/filings/0001171843-24-006945.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006945 |
| 2024-11-01 | 20:50 ET | [SC 13D/A](/filings/0001171843-24-005965.md) | Ownership report, active investor, amended | 0001171843-24-005965 |
| 2024-10-31 | 08:30 ET | [8-K](/filings/0001171843-24-005928.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001171843-24-005928 |
| 2024-10-04 | 16:55 ET | [8-K](/filings/0001171843-24-005515.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001171843-24-005515 |
| 2024-08-09 | 16:45 ET | [10-Q](/filings/0001171843-24-004651.md) | Quarterly report, period 2024-06-30 | 0001171843-24-004651 |
| 2024-08-09 | 16:30 ET | [8-K](/filings/0001171843-24-004649.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004649 |
| 2024-06-24 | 08:31 ET | [8-K](/filings/0001654954-24-008062.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-008062 |
| 2024-05-30 | 17:04 ET | [8-K](/filings/0001654954-24-007083.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-007083 |
| 2024-05-10 | 16:46 ET | [10-Q](/filings/0001654954-24-005971.md) | Quarterly report, period 2024-03-31 | 0001654954-24-005971 |
| 2024-05-10 | 16:23 ET | [8-K](/filings/0001654954-24-005965.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-005965 |

Page 1 of 7. [Older](/companies/edsa/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:02 ET. No prices; not investment advice.